Skip to main navigation

A world of opportunity - Ernst & Young - Switzerland

HomeSpecialist articles / interviewsIssue Health Sciences
Specialist articles / interviews

Specialist articles / interviews

Your selection

Issue Health Sciences

The following items match your selection:
June 2008

2008: The year of the great breakthrough?

The year 2007 was excellent from the financing perspective. New investors pumped more than CHF 885 million into biotechnology, exceeding the previous record from the year 2006.

Jürg Zürcher, Ernst & Young
L'Agéfi 06/08
June 2007

Historic Advances

The global biotech sector reported a record number of products in the pipeline and record inflows of risk capital in 2006. Switzerland, for its part, is the leading biotech location in the world in terms of size and number of inhabitants. And the future of the Swiss biotech industry remains rosy.

Jürg Zürcher, Ernst & Young
Business Guide to Switzerland
April 2007

A Prime Example of a Competitive Business Location

Switzerland is the location of choice for over 137 biotech companies and 81 biotech industry suppliers. In 2006 the Swiss biotech sector generated global revenue of over CHF 6 billion and employed over 14,000 people. In terms of size and number of inhabitants, Switzerland is the leading biotech location in the world.

Jürg Zürcher, Ernst & Young
BIOforum Europe 4/2007

Positive effects on the Swiss economy

Switzerland is the leading biotech location in the world in terms of size and number of inhabitants. Experiencing another successful year in 2006, the Swiss biotechnology industry nevertheless faced some unexpected market developments.

Jürg Zürcher, Ernst & Young
L'Agéfi Biotech, 04/07
Related content
Periodicals

Magazines

 

Annual Reports

 

Newsletter


Ernst & Young Online

Learn more
 
-->
-->
Back to top